Pensacola Pharmaceutical Product Lawyer, Florida


John F. Windham

Litigation, Pharmaceutical Product, Medical Products & Devices, Workers' Compensation, Products Liability
Status:  In Good Standing           

Larry Hill

Class Action, Pharmaceutical Product, Corporate, Medical Malpractice
Status:  In Good Standing           

Marcus Joseph Michles

Pharmaceutical Product, Products Liability, Medical Malpractice, Professional Malpractice
Status:  In Good Standing           Licensed:  38 Years

FREE CONSULTATION 

CONTACT

Jim Mckenzie

Pharmaceutical Product, Insurance, Class Action, Medical Malpractice
Status:  In Good Standing           

Free Help: Use This Form or Call 800-620-0900

Member Representative

Call me for fastest results!
800-620-0900

Free Help: Use This Form or Call 800-620-0900

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.


Free Help: Use This Form or Call 800-943-8690

Member Representative

Call me for fastest results!
800-943-8690

Free Help: Use This Form or Call 800-943-8690

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.

TIPS

Easily find Pensacola Pharmaceutical Product Lawyers and Pensacola Pharmaceutical Product Law Firms. For more attorneys, search all Health Care areas including Medical Products & Devices, Medicare & Medicaid and Other Health Care attorneys.

SAMPLE LEGAL CASES

Abbott Labs. v. MYLAN PHARMACEUTICALS

... "Until the mid-1970s, nearly all states required pharmacists to dispense the exact drug specified by the prescribing physician, even if equivalent generic products were available." Jessie Cheng, An Antitrust Analysis of Product Hopping in the Pharmaceutical Industry, 108 Colum. ...

Abbott Laboratories v. Mylan Pharmaceuticals, Inc.

... "Until the mid-1970s, nearly all states required pharmacists to dispense the exact drug specified by the prescribing physician, even if equivalent generic products were available." Jessie Cheng, An Antitrust Analysis of Product Hopping in the Pharmaceutical Industry, 108 Colum. ...

Webster v. Body Dynamics, Inc.

... Appellee BDI Pharmaceutical's arguments that the FDA's 2004 report banning ephedrine alkaloids did not specifically address Super Mini's also goes to the ... argue to the jury that the ban utilized a cost-benefit analysis and made no determination regarding any specific product. ...